Paulson John's Form 4 filing
Bausch Health Companies Inc. (BHC) · filed Jun 12, 2025
- Accession no.
- 0001013594-25-000742
- Filed
- Jun 12, 2025
- Trade date
- Jun 10-12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $14.7M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Paulson JohnCIK 0001394923 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | Common Stock, no par value | PPurchaseAcquired | +754,134 | $5.05 | +$3,808,376.7 | 27,193,169 | Indirect | |
| Jun 11, 2025 | Common Stock, no par value | PPurchaseAcquired | +1,029,098 | $5.24 | +$5,392,473.52 | 28,222,267 | Indirect | |
| Jun 12, 2025 | Common Stock, no par value | PPurchaseAcquired | +1,005,376 | $5.47 | +$5,499,406.72 | 29,227,643 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.